Andy Stewart is a Senior Management professional with 40 years of experience in the Medical Device Industry. He works as CEO of startup companies in the Med Device arena. He worked for 30 years at J&J, Inc. serving as Vice President of Worldwide Sales and Marketing, Strategic Planning, and Product Management. Andy completed an AMP with Harvard Business School and his BA in economics from Kenyon College. He also served as Chairman of the Board for Somerset Medical Center in New Jersey. Married 44 years to Carolyn. Elder in his church.
Director of Sales
David Stuebe is an accomplished senior manager in the Pharmaceutical arena with over 25 years of experience building marketing strategies, developing and executing training, hiring and leading sales teams to achieve and exceed goals. He has launched many new specialized drugs and devices in many therapeutic areas. These major companies have included Takeda/Abbott Labs, Wyeth, Sanofi and Genzyme. In addition to his Pharmaceutical career, David is a highly decorated Colonel in the United States Marine Reserves serving in many command and operational assignments around the world.
Stuart Cantor, Ph.D.
Chief Scientific Officer
Stuart L. Cantor completed his Ph.D in pharmaceutical sciences at the University of Maryland School of Pharmacy. Dr. Cantor is a scientist with deep expertise in the product development and commercialization of both pharmaceutical and nutraceutical products, has extensive experience assessing all aspects of healthcare intellectual property, and doing business development for start-up companies.
His expertise lies in the development of tablets and capsules, controlled release technologies, and orally disintegrating tablets (ODTs). He previously worked for a pharmaceutical start-up company where he developed several nutraceutical products which were licensed to and commercialized by Bristol Myers Squibb.
Dr. Cantor has published 58 articles in the nutraceutical and pharmaceutical fields dealing with various R&D, processing, ingredient functionality/chemistry, and regulatory topics. He was a pharmaceutical formulation scientist at the Food & Drug Administration (FDA), where he developed solid oral dosage forms (tablets and capsules) and conducted analytical work to support various regulatory issues. He is currently working as a CMC consultant at Agios Pharmaceuticals and previously consulted at Proteus Digital Health where he was involved with developing drug and medical device combination products.
W. Jud Ready, Ph.D.
Dr. W. Jud Ready is the Deputy Director, Innovation Initiatives for the Georgia Tech ‘Institute for Materials.’ He has also been an Adjunct Professor in the School of Materials Science & Engineering at Georgia Tech and a Principal Research Engineer on the research faculty of Georgia Tech Research Institute (GTRI) for over a dozen years. Prior to joining the Georgia Tech faculty, he worked for a major military contractor (General Dynamics) as well as in small business (MicroCoating Technologies). He has served as PI or co-PI for grants totaling ~M awarded by the Army, Navy, Air Force, DARPA, NASA, NSF, NIST, industry, charitable foundations and the States of Georgia and Florida. His current research focuses primarily on energy, aerospace, nanomaterial applications and electronics reliability. Dr. Ready has published numerous refereed publications on electronic and nanoscale materials and his research developments have been presented at well-over two dozen international conferences. He has served as an expert witness in criminal and civil cases and he has provided testimony to the Georgia State House Science & Technology Committee. He has patents awarded in the United States (#6,846,370; 6,994,757; 8,350,146; 8,474,805; 8,604,681; 8,774,890; 8,919,752; 9,058,954) and abroad, with several others pending in the U.S. and abroad as well.
The Electronic, Magnetic and Photonic Materials Division (EMPMD) of The Minerals, Metals and Materials Society (TMS) named Dr. Ready as a 2002 “Young Leader.” He has served as Chair for the TMS Nanotechnology Committee, TMS Education Committee and TMS Membership & Student Development Committee. He was elected to the TMS Board in 2005 (Director, Membership & Student Development) and again in 2010 (Director, Content Development & Dissemination). In 2015, he received the Brimacombe Medal from TMS that rewards a mid-career individuals for sustained excellence and achievement in business, technology, education, public policy, or science related to materials science and engineering. Dr. Ready is also the recipient of the “Innovative Research Award” by GTRI in 2013; the “Outstanding Undergraduate Research Mentor Award” by the Georgia Institute of Technology (2009); the “Young Leader International Scholar Award” by the Japan Institute of Metals (2005); and the “Red Flag Award” by the Georgia Department of Natural Resources (2001). Dr. Ready also serves on the TMS Electronic Packaging and Interconnect Materials Committee and the TMS Public and Government Affairs Committee.
He has also been involved in a variety of peer review activities for archival journals, scholarships and federal agencies and continues to be a session organizer for numerous national and international symposia/conferences. Dr. Ready is also a Senior Member of IEEE, and a member of the Materials Research Society (MRS). Dr. Ready is a helicopter and instrument-rated fixed wing pilot and has served as Board Chairman for the non-profit /501(c)(3) Yellow Jacket Flying Club, Inc. since 2010. He also is a Trustee of the Georgia Tech Athletic Association, as well as the Georgia Tech Alumni Association and recently served on the Georgia Tech Executive Board as well as Faculty Assembly.
- Lucas Campbell
- Gabrielle Esposito
- Emily Fitzharris
- Tara Kovacs
- Matthew Orr
Patricia E. Lafaro RN, BS, CIC
Patricia E. Lafaro RN, BS, CIC is Director of Infection Prevention at Robert Wood Johnson University Hospital and Robert Wood Johnson University Hospital Somerset. Prior to coming to New Jersey Pat practiced infection prevention in New York at Lenox Hill Hospital and Metropolitan Hospital. With over 30 years of infection prevention experience in both acute acre and in the ambulatory setting. She completed her Bachelor’s in Science at Columbia University in New York City and trained in infection prevention at The Center for Disease Control in Atlanta, Georgia. Pat has been certified in infection preventions since 1993, she is also Green belt certified in Lean Six Sigma.
Pat has been an active member of the local APIC-NNJ Chapter serving as treasurer, president-elect, and president as well as the chair of governmental affairs committee. She received the National APIC Chapter Leadership Award in 2008 at the national convention.
Pat has served on many New Jersey Quality Improvement Committees on C.difficile infections and Healthcare Associated Infections Technical Work Group. She has served on the New Jersey Hospital Association (NJHA) Emergency Preparedness Task Force, NJHA Education Task Force for Emergency Preparedness, NJHA Engineering Advisory Board, NJHA Task Force on Pandemic Flu, New Jersey Department of Health (NJDOH) Task Force on Resistant Organisms and a member of the NJDOH Team on MRSA Guidance. She is a member of the APIC and IDSA New Jersey Annual Educational Conference Committee.
Pat has also appeared on several TV news shows in regard to infection related issues. She has also published in the American Journal of Infection Control.
MICHAEL O. CHOO, Previous President & Chief Executive Officer for Los Angeles based Healthcare Corporation. Mr. Choo has over 34+ years of experience in healthcare with expertise in Operational Executive Management, Hospital Turnarounds, Hospital Acquisitions, and Ground Floor Start-ups, many of those years spent in executive positions with various hospitals and hospital management companies. He previously served as Principal, Managing Partner & President & Chief Executive Officer of Integra Healthcare, Inc., Principal, Managing Partner, & Chairman of The Board of Directors of Doctors’ Hospital of Shreveport, and Principal, Managing Partner & Senior Vice President of Operations for Ethicus Healthcare Management, LLC. Mr. Choo was also previously the Senior Vice President of Promise Healthcare, Inc. and Chief Executive Officer of Promise Specialty Hospital of Shreveport, a 146 bed JCAHO long-term acute care, acute rehabilitation, gerontologic and adult psych turnaround hospital located in Shreveport, Louisiana. As second in command of the Company, he had corporate oversight of the Company’s 14 other facilities from the standpoint of corporate recruitment, new business development, and operational turnaround.
Before departing from Promise Healthcare, Inc., Mr. Choo brought over 120+ collective years of corporate operational experience, leadership, structure, “team concept” and organization to the Promise Healthcare Executive team. He has vast experience in the clinical setting as well as the operational and organizational development & structure of hospitals and healthcare organizations to comply with state & federal regulatory agency guidelines. He held a previous position as the Chief Executive Officer of HealthSouth in Reno a 63 Acute Rehabilitation Freestanding Hospital in Reno, NV acting as Team Leader for the HealthSouth Surgical center, and HealthSouth Sports Clinic in Carson City, NV. He also has been the Vice President of NPSI with responsibility for 4 major hospitals in the Los Angeles and San Diego area, and Regional Chief Operations Officer of ARMS with responsibilities for 5 hospital turnarounds and 2 ground floor start-ups. In addition to his hospital management insights, Mr. Choo brings experience from the acute care, LTAC, Behavioral Health, and Acute Rehabilitation industries to the organization. Mr. Choo has completed his Masters degree in Business Administration from California Coast University.
Robert Binford is a practicing cardiothoracic surgeon specializing in complex valve and structural heart surgery with an emphasis on minimally invasive surgery. During his 14 years in practice, he developed two minimally invasive cardiac surgery programs and one robotic heart surgery program. In addition, he trained and proctored several cardiac surgeons in robotic surgery from all over the US and internationally. In addition to being a cardiothoracic surgeon, Robert also has a background in aerospace engineering with research specializing in stability and control, flight test, and advance design. He earned both a Bachelor’s and Master’s of Science from Texas A&M University. NASA funded his graduate research. Robert has never been satisfied with the status quo. He is constantly looking for newer and better ideas and their applications.
Mr. Park is a Certified Hedge Fund Professional (CHP), with additional (CHP) certifications at the highest level in Portfolio Analytics and Risk Management. He attended the Notre Dame Mendoza College of Business (Leadership and Management) and has served in executive leadership positions for over 20 years. Mr. Park has closed several acquisitions and multimillion dollar lines of credit from hedge funds; as well as negotiated and / or closed many mergers, strategic partnerships, license and/or sponsored research agreements and joint ventures. He initiated and signed investment agreements totaling more than 25 million for companies he founded. As an experienced practitioner of business strategy, he has read, studied and applied numerous books and countless articles relating to business strategy (According to the Wall Street Journal, the most sought after executive skill set is strategic thinking).